{"id":"nph-twice-daily","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"NPH (Neutral Protamine Hagedorn) insulin is a suspension of insulin crystals complexed with protamine, which slows insulin absorption from subcutaneous tissue compared to regular insulin. This intermediate duration of action (peak effect 4-8 hours, duration 10-16 hours) makes it suitable for twice-daily dosing regimens in diabetes management. It mimics endogenous insulin secretion by promoting glucose uptake in muscle and adipose tissue while suppressing hepatic glucose production.","oneSentence":"NPH insulin is an intermediate-acting insulin that lowers blood glucose by facilitating cellular glucose uptake and promoting anabolic metabolism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:35:10.669Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT07320963","phase":"PHASE1, PHASE2","title":"Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-31","conditions":"Nasopharyngeal Carcinoma","enrollment":52},{"nctId":"NCT07303283","phase":"PHASE2","title":"Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Kai Hu","startDate":"2026-04-15","conditions":"Nasopharyngeal Carcinoma (NPC), Locoregionally Advanced Nasopharyngeal Carcinoma, Adjuvant Therapy","enrollment":218},{"nctId":"NCT02973386","phase":"PHASE3","title":"Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients","status":"COMPLETED","sponsor":"Sun Yat-Sen University Cancer Center","startDate":"2017-01-13","conditions":"Local Advanced High Risk Nasopharyngeal Carcinoma","enrollment":294},{"nctId":"NCT06976190","phase":"PHASE3","title":"A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Shanghai Miracogen Inc.","startDate":"2025-05-06","conditions":"Recurrent or Metastatic Nasopharyngeal Carcinoma","enrollment":446},{"nctId":"NCT07331428","phase":"PHASE2","title":"MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2026-01-01","conditions":"Nasopharyngeal Carcinoma, Local Recurrence","enrollment":25},{"nctId":"NCT07248670","phase":"PHASE3","title":"Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chongqing University Cancer Hospital","startDate":"2025-10-04","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":252},{"nctId":"NCT07154069","phase":"PHASE3","title":"Adaptive Immunotherapy for Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-11-13","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":802},{"nctId":"NCT05914116","phase":"PHASE1, PHASE2","title":"A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors","status":"RECRUITING","sponsor":"DualityBio Inc.","startDate":"2023-08-17","conditions":"Advanced Solid Tumors","enrollment":862},{"nctId":"NCT07238569","phase":"PHASE3","title":"Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-12-01","conditions":"Nasopharyngeal Cancinoma (NPC), Nasopharangeal Cancer","enrollment":516},{"nctId":"NCT03144661","phase":"PHASE1","title":"An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2017-05-25","conditions":"Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Esophageal Cancer","enrollment":25},{"nctId":"NCT04925544","phase":"PHASE2","title":"Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2022-01-25","conditions":"Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma","enrollment":13},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT07138989","phase":"PHASE2","title":"EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-08-19","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":10},{"nctId":"NCT05322343","phase":"","title":"Biobank and Brain Health in Bordeaux.","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2022-03-22","conditions":"Brain, Aging, Cognitive Aging","enrollment":2050},{"nctId":"NCT07085234","phase":"PHASE2","title":"Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2025-07-30","conditions":"Locally Advanced Nasopharyngeal Carcinoma, Immunotherapy, Induction Therapy","enrollment":30},{"nctId":"NCT07067268","phase":"PHASE2","title":"Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-09-14","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":76},{"nctId":"NCT06811844","phase":"PHASE2","title":"Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2025-02-25","conditions":"Nasopharyngeal Neoplasms, PD-1 Inhibitor, Induction Therapy","enrollment":208},{"nctId":"NCT07035626","phase":"PHASE1, PHASE2","title":"A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2025-06-25","conditions":"Radiation-induced Xerostomia","enrollment":58},{"nctId":"NCT06987123","phase":"PHASE2","title":"TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-05-18","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":62},{"nctId":"NCT06900218","phase":"PHASE3","title":"PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-05-01","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":664},{"nctId":"NCT06892431","phase":"PHASE2","title":"JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Shanghai JMT-Bio Inc.","startDate":"2025-04-01","conditions":"Recurrent or Metastatic Nasopharyngeal Cancer, Patients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy","enrollment":150},{"nctId":"NCT06712888","phase":"PHASE3","title":"Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-02-17","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":466},{"nctId":"NCT06629597","phase":"PHASE3","title":"A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"MediLink Therapeutics (Suzhou) Co., Ltd.","startDate":"2024-12-31","conditions":"Nasopharyngeal Carcinoma","enrollment":400},{"nctId":"NCT06669611","phase":"PHASE3","title":"Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-11-27","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":242},{"nctId":"NCT05869227","phase":"PHASE3","title":"Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"XIANG YANQUN","startDate":"2023-04-28","conditions":"Nasopharyngeal Carcinoma, Maintenance Therapy","enrollment":166},{"nctId":"NCT06664983","phase":"PHASE3","title":"TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-10-21","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":84},{"nctId":"NCT06662344","phase":"NA","title":"Nutrition Tubes on Sleep Quality in Stroke-related Dysphagia","status":"NOT_YET_RECRUITING","sponsor":"Babujinaya Cela","startDate":"2024-11-30","conditions":"Dysphagia","enrollment":140},{"nctId":"NCT05218356","phase":"PHASE2","title":"Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2022-01-20","conditions":"COVID-19","enrollment":130},{"nctId":"NCT06277050","phase":"PHASE3","title":"Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Jiangxi Provincial Cancer Hospital","startDate":"2024-03-07","conditions":"Nasopharyngeal Carcinoma, High-Risk Cancer, Maintenance Therapy","enrollment":264},{"nctId":"NCT06331845","phase":"PHASE2","title":"Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2024-05-01","conditions":"Metastatic Nasopharyngeal Carcinoma, Intermittent Systematic Chemotherapy","enrollment":39},{"nctId":"NCT06328868","phase":"NA","title":"Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Copka Sonpashan","startDate":"2024-03","conditions":"Dysphagia","enrollment":80},{"nctId":"NCT06301672","phase":"NA","title":"Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing Disorders","status":"NOT_YET_RECRUITING","sponsor":"Muhammad","startDate":"2024-03","conditions":"Dysphagia","enrollment":60},{"nctId":"NCT06259721","phase":"PHASE2","title":"Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Jiangxi Provincial Cancer Hospital","startDate":"2024-02-10","conditions":"Nasopharyngeal Carcinoma","enrollment":22},{"nctId":"NCT06248879","phase":"NA","title":"Intermittent Oro-esophageal Tube Feeding in Late Dysphagia for Nasopharyngeal Carcinoma","status":"WITHDRAWN","sponsor":"People's Hospital of Zhengzhou University","startDate":"2024-02-28","conditions":"Dysphagia","enrollment":""},{"nctId":"NCT06265844","phase":"NA","title":"Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Zeng Changhao","startDate":"2024-03-01","conditions":"Dysphagia","enrollment":80},{"nctId":"NCT05893810","phase":"PHASE3","title":"Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis","status":"UNKNOWN","sponsor":"Jiangxi Provincial Cancer Hospital","startDate":"2023-07-01","conditions":"Nasopharyngeal Carcinoma, Radiation-induced Oral Mucositis, Bacterial Colonization","enrollment":176},{"nctId":"NCT00687453","phase":"PHASE4","title":"Insulin Glargine Versus Twice-Daily NPH","status":"TERMINATED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2003-02","conditions":"Type 2 Diabetes Mellitus","enrollment":27},{"nctId":"NCT03200340","phase":"PHASE2","title":"EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation","status":"COMPLETED","sponsor":"Enzychem Lifesciences Corporation","startDate":"2018-07-03","conditions":"Stomatitis","enrollment":105},{"nctId":"NCT02611960","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2016-04-18","conditions":"Nasopharyngeal Neoplasms","enrollment":233},{"nctId":"NCT03187834","phase":"PHASE4","title":"Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-07-04","conditions":"Child Development","enrollment":252},{"nctId":"NCT04328285","phase":"PHASE3","title":"Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2020-04-14","conditions":"COVID-19","enrollment":118},{"nctId":"NCT05717764","phase":"PHASE3","title":"Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment","status":"NOT_YET_RECRUITING","sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","startDate":"2023-02","conditions":"Recurrent Metastatic Nasopharyngeal Carcinoma","enrollment":500},{"nctId":"NCT05512767","phase":"NA","title":"A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2022-12-01","conditions":"Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage IV HPV-Mediated (p16-pos)Oropharyngeal Carcinoma","enrollment":""},{"nctId":"NCT02143388","phase":"PHASE3","title":"Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial","status":"COMPLETED","sponsor":"Zhao Chong","startDate":"2014-03-31","conditions":"Local Advanced High Risk Nasopharyngeal Carcinoma","enrollment":180},{"nctId":"NCT05484375","phase":"PHASE2","title":"Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","startDate":"2022-09","conditions":"Metastatic Nasopharyngeal Carcinoma","enrollment":40},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT04825990","phase":"PHASE2","title":"Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer","status":"RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2022-03-24","conditions":"Nasopharyngeal Carcinoma","enrollment":30},{"nctId":"NCT03350984","phase":"PHASE4","title":"Insulin Schemes for Type 2 Diabetes Control","status":"COMPLETED","sponsor":"Universidad de Guanajuato","startDate":"2017-11-02","conditions":"Type 2 Diabetes Mellitus","enrollment":75},{"nctId":"NCT04930861","phase":"PHASE1","title":"Study of Codivir in Patients With COVID-19","status":"COMPLETED","sponsor":"Code Pharma","startDate":"2021-03-29","conditions":"Covid19","enrollment":12},{"nctId":"NCT03668366","phase":"PHASE2","title":"S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma","status":"COMPLETED","sponsor":"Fudan University","startDate":"2013-08-01","conditions":"Nasopharyngeal Carcinoma","enrollment":133},{"nctId":"NCT04231864","phase":"PHASE2","title":"Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer","status":"WITHDRAWN","sponsor":"Alain Algazi","startDate":"2020-12-01","conditions":"Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma","enrollment":""},{"nctId":"NCT04292990","phase":"PHASE4","title":"Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients","status":"UNKNOWN","sponsor":"Jiarong Chen, MD","startDate":"2020-12","conditions":"Pain, Nasopharyngeal Carcinoma, Head and Neck Cancer","enrollment":300},{"nctId":"NCT04319471","phase":"PHASE2","title":"Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma","status":"UNKNOWN","sponsor":"Fujian Cancer Hospital","startDate":"2020-06-01","conditions":"Nasopharyngeal Carcinoma","enrollment":70},{"nctId":"NCT02456506","phase":"NA","title":"Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-06","conditions":"Nasopharyngeal Neoplasms, Mortality, Quality of Life","enrollment":142},{"nctId":"NCT00821795","phase":"PHASE4","title":"Veterans Inpatient Insulin Study and Transition to Outpatient Therapy","status":"COMPLETED","sponsor":"Dennis G. Karounos, M.D.","startDate":"2009-03-11","conditions":"Type 2 Diabetes Mellitus","enrollment":120},{"nctId":"NCT00656513","phase":"PHASE2, PHASE3","title":"Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-09","conditions":"Head and Neck Cancer, Xerostomia","enrollment":196},{"nctId":"NCT04012775","phase":"PHASE3","title":"Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"Geropharm","startDate":"2017-04-20","conditions":"Diabetes Mellitus, Type 2","enrollment":201},{"nctId":"NCT03049358","phase":"NA","title":"Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer","status":"TERMINATED","sponsor":"Stanford University","startDate":"2016-12","conditions":"Stage 0 Nasopharyngeal Carcinoma, Stage 0 Paranasal Sinus Cancer, Stage I Nasopharyngeal Carcinoma","enrollment":15},{"nctId":"NCT03779594","phase":"PHASE2","title":"Acetazolamide for Treating NPH in Shunt-candidates Patients","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2018-12","conditions":"Normal Pressure Hydrocephalus","enrollment":15},{"nctId":"NCT00590044","phase":"PHASE4","title":"Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)","status":"COMPLETED","sponsor":"Emory University","startDate":"2007-12","conditions":"Diabetic Ketoacidosis","enrollment":74},{"nctId":"NCT02131272","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2014-06-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT00790569","phase":"NA","title":"Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-09","conditions":"Bladder Cancer, Cervical Cancer, Esophageal Cancer","enrollment":315},{"nctId":"NCT00117572","phase":"PHASE3","title":"Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2004-11","conditions":"Cancer of the Pharynx, Cancer of the Larynx, Cancer of the Nasal Cavity","enrollment":285},{"nctId":"NCT00052611","phase":"PHASE2","title":"Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2002-06","conditions":"Head and Neck Cancer","enrollment":23},{"nctId":"NCT00095901","phase":"PHASE2","title":"Capecitabine For Nasopharyngeal Cancer","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2004-06","conditions":"Head and Neck Cancer","enrollment":3},{"nctId":"NCT03427359","phase":"PHASE2","title":"Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma","status":"COMPLETED","sponsor":"The University of Hong Kong-Shenzhen Hospital","startDate":"2015-01-22","conditions":"Nasopharyngeal Carcinoma","enrollment":65},{"nctId":"NCT03112837","phase":"NA","title":"Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.","status":"UNKNOWN","sponsor":"Jiangxi Provincial Cancer Hospital","startDate":"2017-03-10","conditions":"Oral Mucositis, Quality of Life","enrollment":40},{"nctId":"NCT03045484","phase":"NA","title":"Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-05","conditions":"Nasopharyngeal Carcinoma","enrollment":70},{"nctId":"NCT02302716","phase":"PHASE3","title":"A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 2","enrollment":493},{"nctId":"NCT02189395","phase":"PHASE4","title":"Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting","status":"TERMINATED","sponsor":"Riverside University Health System Medical Center","startDate":"2013-04","conditions":"Type 2 Diabetes Mellitus","enrollment":52},{"nctId":"NCT01589653","phase":"PHASE4","title":"Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-05-26","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":155},{"nctId":"NCT00534001","phase":"PHASE2","title":"Bupropion in Helping Adults Stop Smoking","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2006-01","conditions":"Bladder Cancer, Cervical Cancer, Esophageal Cancer","enrollment":95},{"nctId":"NCT01249547","phase":"PHASE2","title":"Nasopharyngeal Carcinoma (NPC) Axitinib","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2010-12","conditions":"Recurrent or Metastatic NPC","enrollment":37},{"nctId":"NCT00435019","phase":"PHASE3","title":"Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-02","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":348},{"nctId":"NCT01720303","phase":"PHASE4","title":"Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-09-19","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":159},{"nctId":"NCT01562561","phase":"PHASE3","title":"Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-06-01","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":213},{"nctId":"NCT01810952","phase":"PHASE4","title":"The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-09","conditions":"Hyperglycemia, Diabetes Mellitus","enrollment":37},{"nctId":"NCT01486940","phase":"PHASE3","title":"Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-03","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":598},{"nctId":"NCT01697657","phase":"PHASE3","title":"Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2001-09","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":131},{"nctId":"NCT00003657","phase":"PHASE2","title":"High-dose ICE With Amifostine","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"1998-07","conditions":"Bladder Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary","enrollment":24},{"nctId":"NCT01707134","phase":"PHASE3","title":"Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1997-09","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":753},{"nctId":"NCT02123498","phase":"PHASE4","title":"The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"","conditions":"Eustachian Tube Dysfunction, Laryngopharyngeal Reflux","enrollment":""},{"nctId":"NCT02222623","phase":"NA","title":"The Inova Type 2 Diabetes Mellitus Study","status":"WITHDRAWN","sponsor":"Inova Health Care Services","startDate":"2015-04","conditions":"Diabetes, Type 2","enrollment":""},{"nctId":"NCT00115570","phase":"PHASE3","title":"Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-04","conditions":"Diabetes Mellitus, Insulin-Dependent","enrollment":572},{"nctId":"NCT02758522","phase":"PHASE4","title":"NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens","status":"COMPLETED","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2013-10","conditions":"Diabetes Mellitus, Hyperglycemia","enrollment":105},{"nctId":"NCT02608073","phase":"PHASE2","title":"A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2004-11","conditions":"Nasopharyngeal Cancer","enrollment":45},{"nctId":"NCT02633176","phase":"PHASE3","title":"Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-01","conditions":"Nasopharyngeal Carcinoma","enrollment":120},{"nctId":"NCT01275183","phase":"EARLY_PHASE1","title":"Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck","status":"COMPLETED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2010-12","conditions":"Head and Neck Cancer","enrollment":5},{"nctId":"NCT01240785","phase":"PHASE4","title":"Metformin Versus Insulin in Gestational Diabetes","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2006-06","conditions":"Gestational Diabetes","enrollment":221},{"nctId":"NCT02278913","phase":"PHASE4","title":"Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay","status":"COMPLETED","sponsor":"Universidad Nacional de Asunción","startDate":"2009-04","conditions":"Hyperglycemia, Diabetes","enrollment":134},{"nctId":"NCT00522210","phase":"NA","title":"Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2008-03","conditions":"Type 1 Diabetes","enrollment":18},{"nctId":"NCT01223131","phase":"PHASE3","title":"Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-02","conditions":"Type 1 Diabetes Mellitus","enrollment":162},{"nctId":"NCT01865201","phase":"PHASE2","title":"Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2009-03","conditions":"Nasopharyngeal Carcinoma, Brain Necrosis","enrollment":154},{"nctId":"NCT00002951","phase":"PHASE2","title":"Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"1996-06","conditions":"Esophageal Cancer, Head and Neck Cancer","enrollment":53},{"nctId":"NCT00040911","phase":"NA","title":"Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-04","conditions":"Brain Tumors, Central Nervous System Tumors, Childhood Germ Cell Tumor","enrollment":17},{"nctId":"NCT00941369","phase":"PHASE4","title":"Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2009-06","conditions":"Diabetes Mellitus, Type 2","enrollment":345},{"nctId":"NCT00993473","phase":"PHASE3","title":"6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2009-10","conditions":"Type 1 Diabetes Mellitus","enrollment":125},{"nctId":"NCT00212108","phase":"PHASE1, PHASE2","title":"A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2003-11","conditions":"Nasopharyngeal Carcinoma","enrollment":22},{"nctId":"NCT01388439","phase":"","title":"Pharmacokinetics of Oseltamivir in Newborns and Infants","status":"COMPLETED","sponsor":"St. Louis Children's Hospital","startDate":"2011-01","conditions":"Prematurity of Fetus","enrollment":19}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":193,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["(Generic)"],"phase":"marketed","status":"active","brandName":"NPH twice-daily","genericName":"NPH twice-daily","companyName":"Charles Drew University of Medicine and Science","companyId":"charles-drew-university-of-medicine-and-science","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NPH insulin is a long-acting basal insulin that lowers blood glucose by facilitating cellular glucose uptake and promoting anabolic metabolism. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}